256 related articles for article (PubMed ID: 36688662)
1. TGF-β/IFN-γ Antagonism in Subversion and Self-Defense of Phase II Coxiella burnetii
Matthiesen S; Christiansen B; Jahnke R; Zaeck LM; Karger A; Finke S; Franzke K; Knittler MR
Infect Immun; 2023 Feb; 91(2):e0032322. PubMed ID: 36688662
[TBL] [Abstract][Full Text] [Related]
2. Both Major Histocompatibility Complex Class I (MHC-I) and MHC-II Molecules Are Required, while MHC-I Appears To Play a Critical Role in Host Defense against Primary Coxiella burnetii Infection.
Buttrum L; Ledbetter L; Cherla R; Zhang Y; Mitchell WJ; Zhang G
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311245
[TBL] [Abstract][Full Text] [Related]
3. Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule.
Shannon JG; Howe D; Heinzen RA
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8722-7. PubMed ID: 15939879
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.
Ochoa-Repáraz J; Sentissi J; Trunkle T; Riccardi C; Pascual DW
Infect Immun; 2007 Dec; 75(12):5845-58. PubMed ID: 17893129
[TBL] [Abstract][Full Text] [Related]
5. Coxiella burnetii-Infected NK Cells Release Infectious Bacteria by Degranulation.
Matthiesen S; Zaeck L; Franzke K; Jahnke R; Fricke C; Mauermeir M; Finke S; Lührmann A; Knittler MR
Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32817330
[TBL] [Abstract][Full Text] [Related]
6. Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.
Chen C; van Schaik EJ; Gregory AE; Vigil A; Felgner PL; Hendrix LR; Faris R; Samuel JE
J Infect Dis; 2019 Jul; 220(4):624-634. PubMed ID: 30938819
[TBL] [Abstract][Full Text] [Related]
7. T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice.
Andoh M; Zhang G; Russell-Lodrigue KE; Shive HR; Weeks BR; Samuel JE
Infect Immun; 2007 Jul; 75(7):3245-55. PubMed ID: 17438029
[TBL] [Abstract][Full Text] [Related]
8. Intact interferon-γ response against Coxiella burnetii by peripheral blood mononuclear cells in chronic Q fever.
Schoffelen T; Textoris J; Bleeker-Rovers CP; Ben Amara A; van der Meer JW; Netea MG; Mege JL; van Deuren M; van de Vosse E
Clin Microbiol Infect; 2017 Mar; 23(3):209.e9-209.e15. PubMed ID: 27876593
[TBL] [Abstract][Full Text] [Related]
9. Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice.
Schoffelen T; Self JS; Fitzpatrick KA; Netea MG; van Deuren M; Joosten LA; Kersh GJ
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):234-9. PubMed ID: 25618420
[TBL] [Abstract][Full Text] [Related]
10. Lack of dendritic cell maturation following infection by Coxiella burnetii synthesizing different lipopolysaccharide chemotypes.
Shannon JG; Howe D; Heinzen RA
Ann N Y Acad Sci; 2005 Dec; 1063():154-60. PubMed ID: 16481507
[TBL] [Abstract][Full Text] [Related]
11. Major Histocompatibility Complex Class II-Restricted, CD4
Ledbetter L; Cherla R; Chambers C; Zhang Y; Mitchell WJ; Zhang G
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31792078
[TBL] [Abstract][Full Text] [Related]
12. Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-gamma mediates its restoration and bacterial killing.
Ghigo E; Capo C; Tung CH; Raoult D; Gorvel JP; Mege JL
J Immunol; 2002 Oct; 169(8):4488-95. PubMed ID: 12370385
[TBL] [Abstract][Full Text] [Related]
13. A simple method for enrichment of phase I Coxiella burnetii.
Anderson MW; Binette P; Richards C; Beare PA; Heinzen RA; Long CM
J Microbiol Methods; 2023 Aug; 211():106787. PubMed ID: 37453478
[TBL] [Abstract][Full Text] [Related]
14. Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection.
Bastos RG; Howard ZP; Hiroyasu A; Goodman AG
Infect Immun; 2017 Jul; 85(7):. PubMed ID: 28438980
[No Abstract] [Full Text] [Related]
15. Recent Advances on the Innate Immune Response to
Sireci G; Badami GD; Di Liberto D; Blanda V; Grippi F; Di Paola L; Guercio A; de la Fuente J; Torina A
Front Cell Infect Microbiol; 2021; 11():754455. PubMed ID: 34796128
[No Abstract] [Full Text] [Related]
16. IFN-gamma-induced apoptosis and microbicidal activity in monocytes harboring the intracellular bacterium Coxiella burnetii require membrane TNF and homotypic cell adherence.
Dellacasagrande J; Ghigo E; Raoult D; Capo C; Mege JL
J Immunol; 2002 Dec; 169(11):6309-15. PubMed ID: 12444137
[TBL] [Abstract][Full Text] [Related]
17. A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever.
Schoffelen T; Sprong T; Bleeker-Rovers CP; Wegdam-Blans MC; Ammerdorffer A; Pronk MJ; Soethoudt YE; van Kasteren ME; Herremans T; Bijlmer HA; Netea MG; van der Meer JW; Joosten LA; van Deuren M
Clin Microbiol Infect; 2014 Jul; 20(7):642-50. PubMed ID: 24118683
[TBL] [Abstract][Full Text] [Related]
18. Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue.
Hedges JF; Robison A; Kimmel E; Christensen K; Lucas E; Ramstead A; Jutila MA
Infect Immun; 2016 Jun; 84(6):1815-1825. PubMed ID: 27068091
[TBL] [Abstract][Full Text] [Related]
19. Immune response and Coxiella burnetii invasion.
Amara AB; Bechah Y; Mege JL
Adv Exp Med Biol; 2012; 984():287-98. PubMed ID: 22711638
[TBL] [Abstract][Full Text] [Related]
20. Viable Coxiella burnetii Induces Differential Cytokine Responses in Chronic Q Fever Patients Compared to Heat-Killed Coxiella burnetii.
Jansen AFM; Dinkla A; Roest HJ; Bleeker-Rovers CP; Schoffelen T; Joosten LAB; Wever PC; van Deuren M; Koets AP
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
